ask="N/A"
ask_size="N/A"
average_daily_volume="833077"
bid="N/A"
bid_size="N/A"
book_value="-0.413"
change="-0.020"
change_from_200_day_moving_average="-0.210"
change_from_50_day_moving_average="-0.099"
change_from_52_week_high="-1.011"
change_From_52_week_low="0.239"
change_in_percent="-3.928%"
close="0.499"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.083"
ebitda="-1.60M"
eps_estimate_current_year="-0.080"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.030"
ex_dividend_date="N/A"
float_shares="133560000"
high="0.525"
high_52_weeks="1.510"
last_trade_date="2/8/2017"
last_trade_price="0.499"
last_trade_size="1899"
last_trade_time="4:02pm"
low="0.490"
low_52_weeks="0.260"
market_capitalization="77.59M"
moving_average_200_day="0.709"
moving_average_50_day="0.598"
name="Navidea Biopharmaceuticals
Inc"
notes="N/A"
one_year_target_price="1.250"
open="0.510"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-29.583%"
percent_change_from_50_day_moving_average="-16.623%"
percent_change_from_52_week_high="-66.954%"
percent_change_from_52_week_low="+91.776%"
previous_close="0.519"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.526"
revenue="22.91M"
shares_outstanding="155494000"
short_ratio="17.200"
stock_exchange="ASE"
symbol="NAVB"
volume="743526"
weeks_range_52="0.260 - 1.510"
